Mukka Proteins Limited has intimated the National Stock Exchange of India Limited and BSE Limited about an upcoming board meeting scheduled for Friday, June 12, 2026. The primary agenda of the meeting is to consider and approve a proposal for raising funds through the issuance of securities.
The company has specified that the fund raising may be conducted through one or more instruments, including but not limited to Preferential Issue, Rights Issue, or any other mode that the board deems appropriate.
In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for dealing in the company's securities has been closed effective Tuesday, June 9, 2026. The trading window will remain closed until 48 hours after the declaration of the outcome of the board meeting.
This trading restriction applies to all Designated Persons and their immediate relatives as defined under the company's code of conduct. The company has duly informed these individuals about the trading window closure.
The disclosure is made under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Impact
Financial impact not quantified in the disclosure. The specific amount of fund raising and instrument details will be determined and disclosed following board approval.